A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Continuous mobility monitoring: what is currently missing for a widespread deployment in clinical and research settings?
2020
Zenodo
Mobility has been recognised as "the sixth vital sign" and its study and quantification usually occur in laboratory or clinical settings. However, it has been shown that free-living gait characteristics have better discriminative validity, especially in diseases characterised by specific mobility dysfunctions as in Parkinson's Disease [1]. Continuous mobility monitoring could indeed detect, measure, and eventually predict mobility loss for providing essential information for personalized
doi:10.5281/zenodo.4463250
fatcat:z4oz2fdvwzcpdnirrk3nlu2qjm